Bivalency as a principle for proteasome inhibition

被引:90
作者
Loidl, G [1 ]
Groll, M [1 ]
Musiol, HJ [1 ]
Huber, R [1 ]
Moroder, L [1 ]
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
polyoxyethylene; x-ray structures;
D O I
10.1073/pnas.96.10.5418
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The proteasome, a multicatalytic protease, is known to degrade unfolded polypeptides with low specificity in substrate selection and cleavage pattern. This lack of well-defined substrate specificities makes the design of peptide-based highly selective inhibitors extremely difficult. However, the x-ray structure of the proteasome from Saccharomyces cerevisiae reveals a unique topography of the six active sites in the inner chamber of the protease, which lends itself to strategies of specific multivalent inhibition. Structure-derived active site separation distances were exploited for the design of homo- and heterobivalent inhibitors based on peptide aldehyde head groups and polyoxyethylene as spacer element. Polyoxyethylene was chosen as a flexible, linear, and proteasome-resistant polymer to mimic unfolded polypeptide chains and thus to allow access to the proteolytic chamber. Spacer lengths were selected that satisfy the inter- and intra-ring distances for occupation of the active sites from the S subsites, X-ray analysis of the proteasome/bivalent inhibitor complexes confirmed independent recognition and binding of the inhibitory head groups, Their inhibitory potencies, which are by 2 orders of magnitude enhanced, compared with pegylated monovalent inhibitors, result from the bivalent binding. The principle of multivaleney, ubiquitous in nature, has been successfully applied in the past to enhance affinity and avidity of ligands in molecular recognition processes. The present study confirms its utility also for inhibition of multicatalytic protease complexes.
引用
收藏
页码:5418 / 5422
页数:5
相关论文
共 39 条
  • [11] INFLUENCE OF POLYVALENCY ON BINDING PROPERTIES OF ANTIBODIES
    CROTHERS, DM
    METZGER, H
    [J]. IMMUNOCHEMISTRY, 1972, 9 (03): : 341 - +
  • [12] Dick LR, 1997, J BIOL CHEM, V272, P182
  • [13] DICK LR, 1994, J IMMUNOL, V152, P3884
  • [14] Conformational constraints for protein self-cleavage in the proteasome
    Ditzel, L
    Huber, R
    Mann, K
    Heinemeyer, W
    Wolf, DH
    Groll, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 279 (05) : 1187 - 1191
  • [15] Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes - Cleavage of proteins and antigenic peptides
    Ehring, B
    Meyer, TH
    Eckerskorn, C
    Lottspeich, F
    Tampe, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2): : 404 - 415
  • [16] Synthesis, kinetic characterization and X-ray analysis of peptide aldehydes as inhibitors of the 20S proteasomes from Thermoplasma acidophilum and Saccharomyces cerevisiae
    Escherich, A
    Ditzel, L
    Musiol, HJ
    Groll, M
    Huber, R
    Moroder, L
    [J]. BIOLOGICAL CHEMISTRY, 1997, 378 (08) : 893 - 898
  • [17] INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN
    FENTEANY, G
    STANDAERT, RF
    LANE, WS
    CHOI, S
    COREY, EJ
    SCHREIBER, SL
    [J]. SCIENCE, 1995, 268 (5211) : 726 - 731
  • [18] NEW INSIGHTS INTO PROTEASOME FUNCTION - FROM ARCHAEBACTERIA TO DRUG DEVELOPMENT
    GOLDBERG, AL
    [J]. CHEMISTRY & BIOLOGY, 1995, 2 (08): : 503 - 508
  • [19] Selective proteasome inhibitors: modulators of antigen presentation?
    Groettrup, M
    Schmidtke, G
    [J]. DRUG DISCOVERY TODAY, 1999, 4 (02) : 63 - 71
  • [20] Peptide antigen production by the proteasome: Complexity provides efficiency
    Groettrup, M
    Soza, A
    Kuckelkorn, U
    Kloetzel, PM
    [J]. IMMUNOLOGY TODAY, 1996, 17 (09): : 429 - 435